Study of the Nasal Intracellular Reservoir of Staphylococcus Aureus in Patients With S. Aureus Bacteremia

Recruiting Observational Study
Bacteria Infection Mechanism
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
405 (estimated)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Staphylococcus aureus bacteremia is a serious infection associated with a high mortality rate (with or without associated infective endocarditis (IE)), long hospital stays and multiple complications, due to the terrain in which it occurs and its secondary localization. They may be community-acquired or healthcare-associated infections. Being a carrier of S. aureus is a known risk factor for S. aur…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Bacteremia * Patient affiliated or entitled to a social security plan * Patient who has signed a consent form to participate in the study. Exclusion Criteria: * Antibiotic therapy in place for more than 5 days at the time of inclusion * Nasal decolonization of S. aureus with…
Contacts

Elisabeth BOTELHO-NEVERS, MD-PhD

(0)477120764

elisabeth.botelho-nevers@chu-st-etienne.fr

CONTACT

Amandine Gagneux-Brunon, MD-PhD

(0)477120356

amandine.gagneux-brunon@chu-st-etienne.fr

CONTACT